Neck circumference is an independent risk factor for hyperuricemia within 3 years in women: a longitudinal study.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 12 2019
accepted: 08 04 2020
revised: 23 02 2020
pubmed: 28 5 2020
medline: 15 5 2021
entrez: 28 5 2020
Statut: ppublish

Résumé

Our previous cross-sectional study revealed the association between neck circumference (NC) and hyperuricemia. This study aimed to further investigate the longitudinal association between NC and hyperuricemia and to compare the strengths of longitudinal association of NC and waist circumference (WC) with hyperuricemia. A total of 4383 subjects without hyperuricemia at baseline were included. Multivariable linear regression was used to assess the association between baseline anthropometric indices and uric acid level at follow-up. Cox regression was used to assess the relationship between baseline anthropometric indices and the risk of future hyperuricemia. A receiver-operating characteristic curve was used to compare the predictive ability of baseline anthropometric indices for future hyperuricemia. Among women, only baseline NC was positively, linearly associated with uric acid level at follow-up (β = 1.75) and risk of future hyperuricemia (p For women, only baseline NC is an independent risk factor of hyperuricemia within 3 years. NC and WC have a similar 3-year predictive ability for hyperuricemia in both genders. Key Points • This is the first study to assess the longitudinal association between neck circumference and hyperuricemia. • According to the results of this study, we propose for the first time that neck circumference is an independent risk factor for hyperuricemia in women in the future, rather than waist circumference. • We found for the first time that neck circumference and waist circumference have similar predictive ability for future hyperuricemia in both genders.

Identifiants

pubmed: 32458241
doi: 10.1007/s10067-020-05095-3
pii: 10.1007/s10067-020-05095-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3757-3767

Subventions

Organisme : National Natural Science Foundation of China
ID : 31672375
Organisme : National Key Research and Development Program of China
ID : 2018YFC1314100

Auteurs

Ping An (P)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Kang Chen (K)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Anping Wang (A)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Xinye Jin (X)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Yulong Chen (Y)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Weijun Gu (W)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Wenhua Yan (W)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Li Zang (L)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Jingtao Dou (J)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Yiming Mu (Y)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China. muyiming@301hospital.com.cn.

Zhaohui Lv (Z)

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China. metabolism301@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH